Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Artivion has taken certain systems
Gilead said Tuesday that it will soon begin Phase 3 testing for a drug it believes could prevent HIV infection with just a single shot
The CMA began investigating Vifor Pharma in January 2024. Credit: Denis Linine / Getty images. The UK’s Competition and Markets Authority (CMA) has received a
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, HER2-negative advanced breast cancer-;as monotherapy in patients
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or
The body mass index (BMI) has long been used to measure body fat, but its influence on breast cancer risk is more complex than previously
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have better survival outcomes than those who received placebo after
Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations, but it has been difficult to discern whether they
Eli Lilly, which has been directing patients to various telehealth sites as it sells its blockbuster obesity medication Zepbound, is broadening its reach, announcing a
TransCon CNP, one of the therapies in the agreement, is currently in clinical development for achondroplasia. Credit: Louis Reed on Unsplash. Er-Kim has extended its